Crosstalk between human DC subsets promotes antibacterial activity and CD8+ T-cell stimulation in response to bacille Calmette-Guérin

European Journal of Immunology

Volumn 44, Issue 1, 2014, Pages 80-92

  Lozza, Laura ^a   Farinacci, Maura ^a,c   Faé, Kellen ^a,d   Bechtle, Marina ^a   Stäber, Manuela ^a   Dorhoi, Anca ^a   Bauer, Mario ^b   Ganoza, Christian ^a   Weber, Stephan ^a   Kaufmann, Stefan H E ^a  

^a MAX PLANCK INSTITUTE FOR INFECTION BIOLOGY   (Germany)

^b HELMHOLTZ CENTRE FOR ENVIRONMENTAL RESEARCH UFZ   (Germany)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^d Janssen Research and Development   (Netherlands)

Author keywords

Bacille Calmette Gu rin (BCG); Human; Plasmacytoid DCs; Tuberculosis

Indexed keywords

BCG VACCINE; CD1C ANTIGEN; CD40 ANTIGEN; CD86 ANTIGEN; CELL ADHESION MOLECULE; CHEMOKINE RECEPTOR CCR7; GRANZYME B; GREEN FLUORESCENT PROTEIN; HLA ANTIGEN; HLA DR ANTIGEN; INTERLEUKIN 1BETA; CD1 ANTIGEN; CD1C PROTEIN, HUMAN; GLYCOPROTEIN; GRANZYME; MEMBRANE ANTIGEN;

ANTIBACTERIAL ACTIVITY; ARTICLE; BOVINE TUBERCULOSIS; CD8+ T LYMPHOCYTE; CELL ACTIVATION; CELL INTERACTION; CELL MATURATION; CELL STIMULATION; CELL SUBPOPULATION; CELLULAR IMMUNITY; CONTROLLED STUDY; ENDOCYTOSIS; ENZYME SYNTHESIS; EX VIVO STUDY; HUMAN; HUMAN CELL; INFECTION SENSITIVITY; MYCOBACTERIUM BOVIS BCG; MYELOID DENDRITIC CELL; PERIPHERAL LYMPHOCYTE; PHAGOCYTOSIS; PLASMACYTOID DENDRITIC CELL; PRIORITY JOURNAL; UPREGULATION; BACTERIAL LOAD; BONE MARROW CELL; CELL COMMUNICATION; CELL CULTURE; CELL DIFFERENTIATION; DENDRITIC CELL; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; METABOLISM; MYCOBACTERIUM BOVIS; MYCOBACTERIUM TUBERCULOSIS; TUBERCULOSIS;

ANTIGENS, CD1; ANTIGENS, SURFACE; BACTERIAL LOAD; CD8-POSITIVE T-LYMPHOCYTES; CELL COMMUNICATION; CELL DIFFERENTIATION; CELLS, CULTURED; DENDRITIC CELLS; GLYCOPROTEINS; GRANZYMES; HUMANS; INTERLEUKIN-1BETA; LYMPHOCYTE ACTIVATION; MYCOBACTERIUM BOVIS; MYCOBACTERIUM TUBERCULOSIS; MYELOID CELLS; TUBERCULOSIS;

EID: 84892459542     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.201343797     Document Type: Article

References (62)

1. WHO, Global Tuberculosis Report 2012. WHO Press, Geneva 2012. http://www.who.int/tb/publications/global_report/en/
2. Urdahl, K. B., Shafiani, S. and Ernst, J. D., Initiation and regulation of T-cell responses in tuberculosis. Mucosal Immunol. 2011. 4: 288-293.
3. Cooper, A. M., Cell-mediated immune responses in tuberculosis. Annu. Rev. Immunol. 2009. 27: 393-422.
4. Colditz, G. A., Brewer, T. F., Berkey, C. S., Wilson, M. E., Burdick, E., Fineberg, H. V. and Mosteller, F., Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis of the published literature. JAMA 1994. 271: 698-702.
5. Trunz, B. B., Fine, P. and Dye, C., Effect of BCG vaccination on childhood tuberculous meningitis and miliary tuberculosis worldwide: a meta-analysis and assessment of cost-effectiveness. Lancet 2006. 367: 1173-1180.
6. Kaufmann, S. H., The contribution of immunology to the rational design of novel antibacterial vaccines. Nat. Rev. Microbiol. 2007. 5: 491-504.
7. Banchereau, J. and Steinman, R. M., Dendritic cells and the control of immunity. Nature 1998. 392: 245-252.
8. Villadangos, J. A. and Schnorrer, P., Intrinsic and cooperative antigen-presenting functions of dendritic-cell subsets in vivo. Nat. Rev. Immunol. 2007. 7: 543-555.
9. Heath, W. R. and Carbone, F. R., Dendritic cell subsets in primary and secondary T cell responses at body surfaces. Nat. Immunol. 2009. 10: 1237-1244.
10. Kassianos, A. J., Hardy, M. Y., Ju, X., Vijayan, D., Ding, Y., Vulink, A. J., McDonald, K. J. et al., Human CD1c (BDCA-1)(+) myeloid dendritic cells secrete IL-10 and display an immuno-regulatory phenotype and function in response to Escherichia coli. Eur. J. Immunol. 2012. 42: 1512-1522.
11. Jarrossay, D., Napolitani, G., Colonna, M., Sallusto, F. and Lanzavecchia, A., Specialization and complementarity in microbial molecule recognition by human myeloid and plasmacytoid dendritic cells. Eur. J. Immunol. 2001. 31: 3388-3393.
12. Caminschi, I., Proietto, A. I., Ahmet, F., Kitsoulis, S., Shin, T. J., Lo, J. C., Rizzitelli, A. et al., The dendritic cell subtype-restricted C-type lectin Clec9A is a target for vaccine enhancement. Blood 2008. 112: 3264-3273.
13. Haniffa, M., Shin, A., Bigley, V., McGovern, N., Teo, P., See, P., Wasan, P. S. et al., Human tissues contain CD141hi cross-presenting dendritic cells with functional homology to mouse CD103+ nonlymphoid dendritic cells. Immunity 2012. 37: 60-73.
14. Jongbloed, S. L., Kassianos, A. J., McDonald, K. J., Clark, G. J., Ju, X., Angel, C. E., Chen, C. J. et al., Human CD141+ (BDCA-3)+ dendritic cells (DCs) represent a unique myeloid DC subset that cross-presents necrotic cell antigens. J. Exp. Med. 2010. 207: 1247-1260.
15. Crozat, K., Guiton, R., Contreras, V., Feuillet, V., Dutertre, C. A., Ventre, E., Vu Manh, T. P. et al., The XC chemokine receptor 1 is a conserved selective marker of mammalian cells homologous to mouse CD8alpha +dendritic cells. J. Exp. Med. 2010. 207: 1283-1292.
16. Poulin, L. F., Salio, M., Griessinger, E., Anjos-Afonso, F., Craciun, L., Chen, J. L., Keller, A. M. et al., Characterization of human DNGR-1 +BDCA3+ leukocytes as putative equivalents of mouse CD8alpha+ dendritic cells. J. Exp. Med. 2010. 207: 1261-1271.
17. Bachem, A., Guttler, S., Hartung, E., Ebstein, F., Schaefer, M., Tannert, A., Salama, A. et al., Superior antigen cross-presentation and XCR1 expression define human CD11c+CD141+ cells as homologues of mouse CD8+ dendritic cells. J. Exp. Med. 2010. 207: 1273-1281.
18. Kadowaki, N., Ho, S., Antonenko, S., Malefyt, R. W., Kastelein, R. A., Bazan, F. and Liu, Y. J., Subsets of human dendritic cell precursors express different toll-like receptors and respond to different microbial antigens. J. Exp. Med. 2001. 194: 863-869.
19. Colonna, M., Trinchieri, G. and Liu, Y. J., Plasmacytoid dendritic cells in immunity. Nat. Immunol. 2004. 5: 1219-1226.
20. Gilliet, M., Cao, W. and Liu, Y. J., Plasmacytoid dendritic cells: sensing nucleic acids in viral infection and autoimmune diseases. Nat. Rev. Immunol. 2008. 8: 594-606.
21. Siegal, F. P., Kadowaki, N., Shodell, M., Fitzgerald-Bocarsly, P. A., Shah, K., Ho, S., Antonenko, S. et al., The nature of the principal type 1 interferon-producing cells in human blood. Science 1999. 284: 1835-1837.
22. Bond, E., Liang, F., Sandgren, K. J., Smed-Sorensen, A., Bergman, P., Brighenti, S., Adams, W. C. et al., Plasmacytoid dendritic cells infiltrate the skin in positive tuberculin skin test indurations. J. Invest. Dermatol. 2012. 132: 114-123.
23. Facchetti, F., De Wolf-Peeters, C., De, V. R., van den Oord, J. J., Pulford, K. A. and Desmet, V. J., Plasmacytoid monocytes (so-called plasmacytoid T cells) in granulomatous lymphadenitis. Hum. Pathol. 1989. 20: 588-593.
24. Michea, P., Vargas, P., Donnadieu, M. H., Rosemblatt, M., Bono, M. R., Dumenil, G. and Soumelis, V., Epithelial control of the human pDC response to extracellular bacteria. Eur. J. Immunol. 2013. 43: 1264-1273.
25. Yoneyama, H., Matsuno, K., Toda, E., Nishiwaki, T., Matsuo, N., Nakano, A., Narumi, S. et al., Plasmacytoid DCs help lymph node DCs to induce anti-HSV CTLs. J. Exp. Med. 2005. 202: 425-435.
26. Piccioli, D., Sammicheli, C., Tavarini, S., Nuti, S., Frigimelica, E., Manetti, A. G., Nuccitelli, A. et al., Human plasmacytoid dendritic cells are unresponsive to bacterial stimulation and require a novel type of cooperation with myeloid dendritic cells for maturation. Blood 2009. 113: 4232-4239.
27. Kuwajima, S., Sato, T., Ishida, K., Tada, H., Tezuka, H. and Ohteki, T., Interleukin 15-dependent crosstalk between conventional and plasmacytoid dendritic cells is essential for CpG-induced immune activation. Nat. Immunol. 2006. 7: 740-746.
28. Tailleux, L., Schwartz, O., Herrmann, J. L., Pivert, E., Jackson, M., Amara, A., Legres, L. et al., DC-SIGN is the major Mycobacterium tuberculosis receptor on human dendritic cells. J. Exp. Med. 2002. 197: 121-127.
29. Geijtenbeek, T. B., van Vliet, S. J., Koppel, E. A., Sanchez-Hernandez, M., Vandenbroucke-Grauls, C. M., Appelmelk, B. and van Kooyk, Y., Mycobacteria target DC-SIGN to suppress dendritic cell function. J. Exp. Med. 2003. 197: 7-17.
30. Mazurek, J., Ignatowicz, L., Kallenius, G., Jansson, M. and Pawlowski, A., Mycobacteria-infected bystander macrophages trigger maturation of dendritic cells and enhance their ability to mediate HIV transinfection. Eur. J. Immunol. 2012. 42: 1192-1202.
31. Gerosa, F., Baldani-Guerra, B., Lyakh, L. A., Batoni, G., Esin, S., Winkler-Pickett, R. T., Consolaro, M. R. et al., Differential regulation of interleukin 12 and interleukin 23 production in human dendritic cells. J. Exp. Med. 2008. 205: 1447-1461.
32. Segura, E., Touzot, M., Bohineust, A., Cappuccio, A., Chiocchia, G., Hosmalin, A., Dalod, M. et al., Human inflammatory dendritic cells induce Th17 cell differentiation. Immunity 2013. 38: 336-348.
33. Stary, G., Bangert, C., Tauber, M., Strohal, R., Kopp, T. and Stingl, G., Tumoricidal activity of TLR7/8-activated inflammatory dendritic cells. J. Exp. Med. 2007. 204: 1441-1451.
34. Matsui, T., Connolly, J. E., Michnevitz, M., Chaussabel, D., Yu, C. I., Glaser, C., Tindle, S. et al., CD2 distinguishes two subsets of human plasmacytoid dendritic cells with distinct phenotype and functions. J. Immunol. 2009. 182: 6815-6823.
35. Kalb, M. L., Glaser, A., Stary, G., Koszik, F. and Stingl, G., TRAIL(+) human plasmacytoid dendritic cells kill tumor cells in vitro: mechanisms of imiquimod- and IFN-alpha-mediated antitumor reactivity. J. Immunol. 2012. 188: 1583-1591.
36. Tel, J., Smits, E. L., Anguille, S., Joshi, R. N., Figdor, C. G. and de Vries, I. J., Human plasmacytoid dendritic cells are equipped with antigen-presenting and tumoricidal capacities. Blood 2012. 120: 3936-3944.
37. Jahrsdorfer, B., Vollmer, A., Blackwell, S. E., Maier, J., Sontheimer, K., Beyer, T., Mandel, B. et al., Granzyme B produced by human plasmacytoid dendritic cells suppresses T-cell expansion. Blood 2010. 115: 1156-1165.
38. Cella, M., Jarrossay, D., Facchetti, F., Alebardi, O., Nakajima, H., Lanzavecchia, A. and Colonna, M., Plasmacytoid monocytes migrate to inflamed lymph nodes and produce large amounts of type I interferon. Nat. Med. 1999. 5: 919-923.
39. Facchetti, F., Vermi, W., Mason, D. and Colonna, M., The plasmacytoid monocyte/interferon producing cells. Virchows Arch. 2003. 443: 703-717.
40. Chowdhury, D. and Lieberman, J., Death by a thousand cuts: granzyme pathways of programmed cell death. Annu. Rev. Immunol. 2008. 26: 389-420.
41. Drobits, B., Holcmann, M., Amberg, N., Swiecki, M., Grundtner, R., Hammer, M., Colonna, M. et al., Imiquimod clears tumors in mice independent of adaptive immunity by converting pDCs into tumor-killing effector cells. J. Clin. Invest. 2012. 122: 575-585.
42. Metkar, S. S., Menaa, C., Pardo, J., Wang, B., Wallich, R., Freudenberg, M., Kim, S. et al., Human and mouse granzyme A induce a proinflammatory cytokine response. Immunity 2008. 29: 720-733.
43. Afonina, I. S., Tynan, G. A., Logue, S. E., Cullen, S. P., Bots, M., Luthi, A. U., Reeves, E. P. et al., Granzyme B-dependent proteolysis acts as a switch to enhance the proinflammatory activity of IL-1alpha. Mol. Cell 2011. 44: 265-278.
44. Spencer, C. T., Abate, G., Sakala, I. G., Xia, M., Truscott, S. M., Eickhoff, C. S., Linn, R. et al., Granzyme A produced by gamma(9)delta(2) T cells induces human macrophages to inhibit growth of an intracellular pathogen. PLoS Pathog. 2013. 9: e1003119.
45. Shi, L., Chen, G., MacDonald, G., Bergeron, L., Li, H., Miura, M., Rotello, R. J. et al., Activation of an interleukin 1 converting enzyme-dependent apoptosis pathway by granzyme B. Proc. Natl. Acad. Sci. USA 1996. 93: 11002-11007.
46. Fremond, C. M., Togbe, D., Doz, E., Rose, S., Vasseur, V., Maillet, I., Jacobs, M. et al., IL-1 receptor-mediated signal is an essential component of MyD88-dependent innate response to Mycobacterium tuberculosis infection. J. Immunol. 2007. 179: 1178-1189.
47. Mayer-Barber, K. D., Barber, D. L., Shenderov, K., White, S. D., Wilson, M. S., Cheever, A., Kugler, D. et al., Caspase-1 independent IL-1beta production is critical for host resistance to mycobacterium tuberculosis and does not require TLR signaling in vivo. J. Immunol. 2010. 184: 3326-3330.
48. Jayaraman, P., Sada-Ovalle, I., Nishimura, T., Anderson, A. C., Kuchroo, V. K., Remold, H. G. and Behar, S. M., IL-1beta promotes antimicrobial immunity in macrophages by regulating TNFR signaling and caspase-3 activation. J. Immunol. 2013. 190: 4196-4204.
49. Martin, C. J., Booty, M. G., Rosebrock, T. R., Nunes-Alves, C., Desjardins, D. M., Keren, I., Fortune, S. M. et al., Efferocytosis is an innate antibacterial mechanism. Cell Host Microbe 2012. 12: 289-300.
50. Winau, F., Weber, S., Sad, S., de Diego, J., Hoops, S. L., Breiden, B., Sandhoff, K. et al., Apoptotic vesicles crossprime CD8 T cells and protect against tuberculosis. Immunity 2006. 24: 105-117.
51. Le Bon, A., Etchart, N., Rossmann, C., Ashton, M., Hou, S., Gewert, D., Borrow, P. et al., Cross-priming of CD8+ T cells stimulated by virus-induced type I interferon. Nat. Immunol. 2003. 4: 1009-1015.
52. Santini, S. M., Lapenta, C., Logozzi, M., Parlato, S., Spada, M., Di, P. T. and Belardelli, F., Type I interferon as a powerful adjuvant for monocyte-derived dendritic cell development and activity in vitro and in Hu-PBL-SCID mice. J. Exp. Med. 2000. 191: 1777-1788.
53. Tough, D. F., Borrow, P. and Sprent, J., Induction of bystander T cell proliferation by viruses and type I interferon in vivo. Science 1996. 272: 1947-1950.
54. Takagi, H., Fukaya, T., Eizumi, K., Sato, Y., Sato, K., Shibazaki, A., Otsuka, H. et al., Plasmacytoid dendritic cells are crucial for the initiation of inflammation and T cell immunity in vivo. Immunity 2011. 35: 958-971.
55. Morel, C., Badell, E., Abadie, V., Robledo, M., Setterblad, N., Gluckman, J. C., Gicquel, B. et al., Mycobacterium bovis BCG-infected neutrophils and dendritic cells cooperate to induce specific T cell responses in humans and mice. Eur. J. Immunol. 2008. 38: 437-447.
56. Segura, E., Durand, M. and Amigorena, S., Similar antigen cross-presentation capacity and phagocytic functions in all freshly isolated human lymphoid organ-resident dendritic cells. J. Exp. Med. 2013. 210: 1035-1047.
57. Cohn, L., Chatterjee, B., Esselborn, F., Smed-Sorensen, A., Nakamura, N., Chalouni, C., Lee, B. C. et al., Antigen delivery to early endosomes eliminates the superiority of human blood BDCA3+ dendritic cells at cross presentation. J. Exp. Med. 2013. 210: 1049-1063.
58. Tel, J., Schreibelt, G., Sittig, S. P., Mathan, T. S., Buschow, S. I., Cruz, L. J., Lambeck, A. J. et al., Human plasmacytoid dendritic cells efficiently cross-present exogenous Ags to CD8+ T cells despite lower Ag uptake than myeloid dendritic cell subsets. Blood 2013. 121: 459-467.
59. Kaufmann, S. H., Hussey, G. and Lambert, P. H., New vaccines for tuberculosis. Lancet 2010. 375: 2110-2119.
60. Kaufmann, S. H., Tuberculosis vaccine development: strength lies in tenacity. Trends Immunol. 2012. 33: 373-379.
61. Zaba, L. C., Fuentes-Duculan, J., Steinman, R. M., Krueger, J. G. and Lowes, M. A., Normal human dermis contains distinct populations of CD11c+BDCA-1+ dendritic cells and CD163+FXIIIA+ macrophages. J. Clin. Invest. 2007. 117: 2517-2525.
62. Kremer, L., Baulard, A., Estaquier, J., Poulain-Godefroy, O. and Locht, C., Green fluorescent protein as a new expression marker in mycobacteria. Mol. Microbiol. 1995. 17: 913-922.